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Fetal prostate development is initiated by androgens and patterned by androgen dependent and
independent signals. How these signals integrate to control epithelial cell differentiation and prostatic
bud patterning is not fully understood. To test the role of beta-catenin (Ctnnb1) in this process, we used
a genetic approach to conditionally delete or stabilize Ctnnb1 in urogenital sinus (UGS) epithelium from
which the prostate derives. Two opposing mechanisms of action were revealed. By deleting Ctnnb1, we
found it is required for separation of UGS from cloaca, emergence or maintenance of differentiated UGS
basal epithelium and formation of prostatic buds. By genetically inducing a patchy subset of UGS
epithelial cells to express excess CTNNB1, we found its excess abundance increases Bmp expression and
leads to a global impairment of prostatic bud formation. Addition of NOGGIN partially restores prostatic
budding in UGS explants with excess Ctnnb1. These results indicate a requirement for Ctnnb1 in UGS
basal epithelial cell differentiation, prostatic bud initiation and bud spacing and suggest some of these
actions are mediated in part through activation of BMP signaling.
& 2013 Elsevier Inc. All rights reserved.Introduction
Mouse prostate development initiates from a subcompartment
of the lower urogenital tract known as the deﬁnitive urogenital
sinus (UGS). The UGS must complete a series of developmental
events to initiate a normal prostate. One requirement is appro-
priate UGS epithelial differentiation. The mouse UGS forms from
cloacal endoderm at around mouse embryonic day (E)13. Primitive
UGS epithelium then differentiates into a multilayered transitional
epithelium consisting of basal, intermediate and superﬁcial layers
(Abler et al., 2011a). It is generally believed formation of histolo-
gically normal prostatic ducts in mice requires basal epithelium, as
evidenced by the abnormal prostate ductal phenotype in mice
deﬁcient in the basal epithelial cell transcription factor transfor-
mation related protein 63 (Trp63) (Kurita et al., 2004; Signoretti
et al., 2005; Signoretti et al., 2000). However, there is conﬂicting
evidence about whether basal epithelium is required for thell rights reserved.
).earliest stage of prostate ductal development, prostatic bud for-
mation. Kurita et al. (2004) observed in the formation of epithelial
evaginations that histologically resembled prostatic buds in mice
lacking basal epithelium. However, Signoretti et al. (2000, 2005)
reported that prostatic buds do not form in the absence of basal
epithelium. It is further unknown how primitive UGS epithelium,
marked by TRP63 protein undergoes maturation to form a mature
keratin 14 (KRT14)-positive UGS basal epithelium.
Prostatic development also requires appropriate androgen
receptor (AR) activation. Testicular androgens activate AR signal-
ing in UGS mesenchyme, which induces prostatic bud formation
in UGS epithelium (Cunha et al., 1987; Lasnitzki and Mizuno,
1980). Mouse prostatic buds emerge as solid basal epithelial
outgrowths and later arborize and differentiate into a pseudos-
tratiﬁed prostate ductal epithelium consisting of neuroendocrine,
basal and luminal epithelial cells. Mouse and rat prostatic buds
are patterned along two asymmetric axes (dorsoventral, cranio-
caudal) and one symmetrical axis (mediolateral) to give rise to a
ductal network organized into ventral, anterior, dorsal and lateral
prostate lobes (Cunha et al., 1987; Timms et al., 1994). In turn,
UGS epithelium reciprocally interacts with UGS stroma to pattern
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How prostatic buds are patterned is not fully known.
Though many questions remain regarding mechanisms of nor-
mal prostate development, there is evidence that CTNNB1 is likely to
participate in prostatic bud formation. Ctnnb1 has been identiﬁed in
almost every structure that undergoes a budding program; its
activation is necessary and/or sufﬁcient for speciﬁcation of hair
follicle buds (Gat et al., 1998; Lo Celso et al., 2004), mammary gland
buds (Faraldo et al., 2006), feather buds (Noramly et al., 1999;
Widelitz et al., 2000) and tooth buds (Liu et al., 2008). Potential
CTNNB1-stabilizing WNT ligands are abundant in male mouse UGS
during epithelial differentiation, prostatic bud formation and pro-
static branching morphogenesis (Mehta et al., 2011; Yu et al., 2009;
Zhang et al., 2006). CTNNB1-responsive Axin2 and lymphoid enhan-
cer binding factor 1 (Lef1) mRNAs are present in basal epithelial cell
precursors of the deﬁnitive UGS (Abler et al., 2012) and later localize
to developing prostatic bud tip epithelium (Mehta et al., 2011; Wu
et al., 2011). While these data indicate a role for CTNNB1 in prostate
development, there is growing controversy over its exact function.
Some evidence supports a role for CTNNB1 in promoting prostatic
budding and branching (Joesting et al., 2008), especially during bud
speciﬁcation when CTNNB1 is required (Simons et al., 2012). Other
evidence supports an inhibitory role, especially during prostatic
ductal branching morphogenesis (Wang et al., 2008; Yu et al., 2009).
In this manuscript, we examined the impact of genetically
deleting or inducing excess CTNNB1 expression in UGS epithelium.
We speciﬁcally sought to identify the CTNNB1 role in UGS epithe-
lium because we previously identiﬁed a sexually dimorphic and
male dominant pattern of CTNNB1-responsive gene expression in
this tissue compartment (Mehta et al., 2011). We show that Ctnnb1
is needed in UGS epithelium for prostatic bud formation and for
formation of UGS basal epithelium. In contrast, we found that
expression of excess CTNNB1 in a patchy subset of UGS epithelial
cells increases BMP ligand expression in the same cells, increases
BMP signaling in surrounding cells, and globally inhibits prostatic
bud formation. The latter role positions CTNNB1 to participate in the
mechanism bywhich prostatic bud spacing intervals are established.
Because it fulﬁlls at least two roles during prostate development,
titration of CTNNB1 signaling is crucial for establishing the normal
pattern and number of mouse prostatic buds.Materials and Methods
Mice
Mice were housed as described previously (Mehta et al., 2011).
All procedures were approved by the University of Wisconsin Animal
Care and Use Committee. Mice carrying the R26R allele (Gt(ROSA)26-
Sortm1Sor), Ctnnb1 exon 2–6 targeted deletion loss-of-function (LOF)
allele (Ctnnb1tm2Kem) or the Ctnnb1 exon 3 targeted deletion gain-of-
function (GOF) allele (Ctnnb1tm1Mmt) were mated to wild type mice
or to mice carrying Shhcre (Shhtm1(EGFP/cre)Cjt) or ShhcreERT2 (Shhtm2(cre/
ERT2)Cjt). To induce ShhcreERT2, dams were injected with sterile corn oil
(2.5 ml/kg i.p. maternal dose) containing 10% ethanol, tamoxifen
(25 mg/kg maternal dose, Sigma #T56482, St. Louis MO) and
progesterone (18.75 mg/kg maternal dose, Watson #NDC0591-
3128-79, Corona CA) and dams were euthanized by CO2 asphyxia-
tion. Embryos of the following genotypes were assessed alone or
together with their phenotypically normal paired littermate con-
trols: Shhcre/þ;R26R, Shhþ /þ;R26R, ShhcreERT2/þ;R26R, Shhþ /þ;
R26R, conditional Ctnnb1 loss-of-function (cLOF) Ctnnb1cLOF (Shhcre/þ;
Ctnnb1tm2Kem/tm2Kem) and its paired control (Shhcre/þ;Ctnnb1tm2Kem/þ),
inducible Ctnnb1 loss-of-function (iLOF) Ctnnb1iLOF (ShhcreERT2/þ;
Ctnnb1tm2Kem/tm2Kem) and its paired control (Shhþ /þ;Ctnnb1tm2Kem/
tm2Kem) or Ctnnb1iLOF;R26R (ShhCreERT2/þ;Ctnnb1tm2Kem/tm2Kem;R26Rþ)and its paired control (ShhCreERT2/þ; Ctnnb1tm2Kem/þR26Rþ), inducible
Ctnnb1 gain-of-function (iGOF) Ctnnb1iGOF (ShhcreERT2/þ;Ctnnb1
tm1Mmt/tm1Mmt) and its paired control (Shhþ /þ; Ctnnb1tm1Mmt/tm1Mmt)
(Brault et al., 2001; Harada et al., 1999; Harfe et al., 2004; Soriano,
1999). Ctnnb1 tm1Mmtmice were from Dr. Makoto Mark Taketo, Kyoto
University, and all other mice were from The Jackson Laboratory. The
morning of copulatory plug identiﬁcation was considered E0.5.
Genotyping primer sequences are listed in Supplementary Material
Table S1.
Assay for b-galactosidase activity
LacZ-dependent b-galactosidase activity was assessed as
described previously (Cheng et al., 1993) with modiﬁcations
described by Mehta et al. (2011).
Immunohistochemistry (IHC)
For most IHC analyses, UGS tissues were ﬁxed in 4% parafor-
maldehyde, dehydrated in ethanol, cleared in xylene, inﬁltrated
with parafﬁn and stained as described previously (Mehta et al.,
2011). To preserve color intensity in LacZ-stained samples, tissues
were cleared in XS-3 xylene substitute (Statlab, McKinney, TX)
prior to parafﬁn inﬁltration. Antibodies are listed in Supplemen-
tary Material Table S2. Labeling of TRP63 and CTNNB1 in the same
tissue section required using primary antibodies from the same
mouse host. The ﬁrst primary and secondary antibody were
added in sequence, tissues were then blocked with unlabeled
monovalent anti-mouse IgG and the second primary and second-
ary antibody were added in sequence. Immunolabeled tissues
were counterstained with 40,6-diamidino-2-phenylindole, dilac-
tate (DAPI) and mounted in anti-fade media (phosphate-buffered
saline containing 80% glycerol and 0.2% n-propyl gallate).
In situ hybridization (ISH)
Detailed protocols are available at www.gudmap.org and were
described previously (Abler et al., 2011b). Primer sequences for
generating PCR-ampliﬁed probe templates are listed in Supplemen-
tary Material Table S3, except for Bmp4 (Feng et al., 1995) and Fgf10
(Bellusci et al., 1997), which were generated from plasmid DNA. Some
ISH-stained tissues were also immunolabeled using previously
described protocols (Abler et al., 2011b; Keil et al., 2012). The staining
pattern for each hybridized riboprobe was assessed in at least three
litter-independent mice per genotype. Control and mutant tissues
were processed together in the same tubes and as a single experi-
mental unit to allow for qualitative comparisons among biological
replicates and between genotypes or treatment groups.
UGS organ culture
Dissected UGSs were placed on 0.4 mm Millicell-CM ﬁlters and
cultured as described previously (Vezina et al., 2008) in media
containing 5a-dihydrotestosterone (DHT, diluted from an ethanol
stock solution to a 10 nM ﬁnal media concentration). The follow-
ing supplements were added alone or in combination with organ
culturemedia: 4-hydroxytamoxifen (Sigma #H6278, 470% Z-isomer,
dissolved in ethanol and diluted in media to 1 mM 4-hydroxy-
tamoxifen and 0.1% ethanol), or recombinant NOGGIN protein (R&D
Systems, dissolved in saline and diluted in media to 1 mg/ml). Media
and supplements were changed every 2 days.
Scanning electron microscopy
Scanning electron microscopy was conducted as described pre-
viously (Lin et al., 2003) at the University of Wisconsin Biological and
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Specimens were imaged from multiple angles to visualize budding
across the entire surface of the UGS epithelium.
Statistics
All experimental groups consisted of three to ﬁve UGSs from at
least three independent litters. Results are reported as mean7-
standard error of the mean (SE). Prostatic bud number per UGS
was calculated by averaging counts from three individuals
blinded to experimental conditions. Only prostatic bud stalks
were counted; a bud with one or more branches was counted as
one bud. The percentage of UGS cells expressing CTNNB1, Ki67,
KRT14 or combinations thereof was determined by counting the
labeled cell fraction in a region bounded cranially by the bladder
neck and caudally by the ejaculatory duct in three nonadjacent
sections per UGS. The Companion to Applied Regression (CAR)
package for R (version 2.13.1) was used for statistical analyses
(Fox and Weisberg, 2011). Student’s t-test was conducted on
untransformed data that passed Levene’s test for homogeneity of
variance and appeared to be normally distributed.Fig. 1. Ctnnb1 deletion from early-stage mouse UGS epithelium (UGE) impairs
cloacal division, prostate ﬁeld speciﬁcation and formation of prostatic buds and
KRT14þ basal epithelium. (A), (B) Electron micrographs of E17.5 Shhcre/þ;
Ctnnb1tm2Kem/þ (control) and Shhcre/þ; Ctnnb1tm2Kem/tm2Kem (Ctnnb1cLOF) UGE after
removal of overlying UGS stroma. Prostatic buds are pseudocolored red. Arrow
indicates an inappropriate hindgut-UGE connection (rectourethral ﬁstula, rf) in
Ctnnb1cLOF mice. (C),(D) E17.5 male UGSs were stained by ISH to visualize the
prostatic bud marker Nkx3-1 (purple) and counterstained by IHC to visualize UGE
marked by cadherin 1 (CDH1). (E)–(H) E17.5 UGS sections were immunoﬂuores-
cently labeled to detect CTNNB1, CDH1 and the UGS basal epithelial cell marker
KRT14. Nuclei were stained with DAPI. Staining patterns in each panel represent
three males. Abbreviations are bl: bladder, bn: bladder neck, hg: hindgut, sv:
seminal vesicle, wd: Wolfﬁan duct. Arrowheads indicate prostatic buds.Results
Ctnnb1 deletion from early-stage mouse UGS epithelium (UGE)
impairs cloacal division, prostate ﬁeld speciﬁcation, and formation of
prostatic buds and KRT14þ basal epithelium
In an earlier study, we observed that CTNNB1-responsive Axin2
and Lef1 mRNAs are more abundant in male compared to female
UGE and are particularly abundant in male prostatic bud tip
epithelium (Mehta et al., 2011). This fact led us to hypothesize
that prostatic bud formation requires CTNNB1 signaling speciﬁcally
in UGE. To test this possibility, we generated a conditional Ctnnb1
loss of function (cLOF) mutant using the Shhcre knock-in allele
(Harfe et al., 2004) which is selectively expressed in UGE but not
elsewhere in the UGS (supplementary material Fig. S1A–C). On its
own, a Shh knock-in allele does not interfere with prostatic bud
formation (supplementary material Fig. S2). Effective Shhcre-
mediated recombination is supported by the loss of detectable
CTNNB1 protein in E17.5 Ctnnb1cLOF mutant UGE (Fig. 1). Control
and Ctnnb1cLOF mutant male UGE morphology was assessed by
enzymatically digesting UGSs with trypsin, removing mesenchyme
and visualizing the underlying UGE by scanning electron micro-
scopy (Fig. 1A, B). Ctnnb1cLOF mouse UGEs are smaller than those of
control littermates, often lack a pelvic urethra and are attached to
the hindgut by a ﬁstulous connection (a rectourethral ﬁstula or
anal atresia phenotype). A requirement for Ctnnb1 in prostate
speciﬁcation, prostatic bud initiation or both is suggested by an
epithelial bud deﬁciency in Ctnnb1cLOF UGEs at a stage when
numerous buds are visible in control UGEs. Intact E17.5 control
and Ctnnb1cLOF UGSs were then stained for Nkx3-1 to determine
whether Ctnnb1cLOF mouse prostate development arrests at the
prostate speciﬁcation or bud initiation stage. Nkx3-1 marks the
prostate ﬁeld at E15.5, approximately one day prior to prostatic
bud formation in control UGS (Keil et al., 2012; Sciavolino et al.,
1997) but is undetectable in Ctnnb1cLOF UGSs (Fig. 1C, D), suggest-
ing a failure to undergo prostate speciﬁcation.
The Ctnnb1cLOF mutant UGE is thinner than control UGE
(Fig. 1E, F), suggestive of possible changes in epithelial composi-
tion. We speciﬁcally examined whether Ctnnb1cLOF mutants form
UGS basal epithelium. Ctnnb1cLOF mutant UGE lacks detectable
KRT14þ basal epithelium (Fig. 1G, H) even though this multi-cell
layer forms at least two days earlier in control UGS (supplemen-
tary material Fig. S3). Together, these results indicate Ctnnb1requirements in cloacal division, speciﬁcation of the prostate
ﬁeld, formation of prostatic buds and formation or maintenance
of KRT14þ UGS basal epithelium.
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formation but not formation of mature KRT14þ basal epithelium
Rectourethral ﬁstula and hypoplastic UGE in Ctnnb1cLOF mice
support a direct Ctnnb1 role in UGS morphogenesis from cloaca.
Yet, these results do not shed light on whether Ctnnb1 is
implicated directly in UGS cell differentiation or prostatic bud
formation because these events occur after and likely depend on
normal cloacal division. We therefore utilized an inducible cre
driver, ShhcreERT2, as a means to delete Ctnnb1 from UGE at a later
developmental stage, after cloacal division but prior to and during
prostatic bud formation.
We optimized the tamoxifen dosing regimen to activate
ShhcreERT2 near the end of cloacal division (Seifert et al., 2008).
We tested two tamoxifen doses (25 and 50 mg/kg maternal doses)
and two dosing periods (once daily intraperitoneal injections to
the dam on E13.5 and E14.5 or on E14.5 and E15.5). Progesterone
(18.75 mg/kg, maternal dose) was co-administered as an anti-
abortifacient. We determined that the 25 mg/kg tamoxifen mater-
nal dose, given in combination with 18.75 mg/kg progesterone at
E13.5 and E14.5, was the highest and latest tolerable in vivo
tamoxifen dose which consistently maintained pregnancy until
E18.5, the embryonic stage when prostatic bud formation is
completed in male embryos. This dosing paradigm activates
ShhcreERT2 in a patchy subset (mosaic) of UGE cells beginning at
E15.5 and persisting until at least E18.5 (supplementary material
Fig. S1D–F, G) and does not interfere with cloacal division or alter
the total number of prostatic buds formed per UGS, although itFig. 2. Ctnnb1 deletion from late-stage mouse UGE impairs prostatic bud formation but no
(control) and ShhcreERT2/þ;Ctnnb1tm2Kem/tm2Kem (Ctnnb1iLOF) embryos were exposed to tamox
visualize Nkx3-1 (purple) and counterstained by IHC to visualize UGE marked by CDH1. B
buds and green arrowheads are dorsolateral prostatic buds. (C) Nkx3-1þ bud numbers are
indicate signiﬁcant differences from controls (po0.05). (D)–(G) Near mid-sagittal section
visualize CTNNB1, CDH1 and KRT14. Cell nuclei are stained with DAPI (blue). Arrowheads i
immunonegative cell. Abbreviations are bl: bladder, sv: seminal vesicle.does cause a small but signiﬁcant (p¼0.046) decrease in ventral
prostatic bud number (supplementary material Fig. S4).
We generated Ctnnb1iLOF (ShhcreERT2/þ;Ctnnb1tm2Kem/tm2Kem)
embryos and exposed them to tamoxifen and progesterone on
E13.5 and E14.5. At E18.5, Ctnnb1iLOF UGSs are comparable in size
to ShhcreERT2/þ;Ctnnb1tm2Kem/þ littermate controls but have fewer
ventral, dorsolateral and total prostatic buds (Fig. 2A–C). There
were more prostatic buds in Ctnnb1iLOF mice (Fig. 2) than in
Ctnnb1cLOF mice (Fig. 1). We suspect that the latter stage of cre
activation (E15.5 in Ctnnb1iLOF mice versus E9.5 in Ctnnb1cLOF
mice) and pharmacokinetic limitations of tamoxifen-dependent
cre activation in Ctnnb1iLOF mice (limited tamoxifen distribution,
incomplete metabolic activation and sub-effective dosing) are
largely responsible for the milder prostatic budding impairment
phenotype in Ctnnb1iLOF compared to Ctnnb1cLOF embryos.
We next investigated UGS histological phenotype of E18.5 male
control and Ctnnb1iLOF UGSs (Fig. 2D–G). The most noteworthy
phenotypic difference is a ubiquitous CTNNB1 protein expression in
control UGE compared to a loss of CTNNB1 protein expression in a
mosaic of Ctnnb1iLOF UGE (Fig. 2D, E). UGE thickness is comparable
and a well organized KRT14þ basal epithelium is present in both
genotypes (Fig. 2F, G). Remarkably, when we determined the percent
of CTNNB1-immunonegative cells in Ctnnb1iLOF UGE in Fig. 2E
(15.572.2%), it closely matches the percent reduction in total
Nkx3-1þ prostatic bud number in these mice compared to controls
in Fig. 2C (16.6%). Even in the presence of a histologically normal UGS
basal epithelium, these results suggest a tight relationship between
the number of CTNNB1þ epithelial cells and prostatic buds formed.t KRT14þ mature UGS basal epithelium formation. Male Shhþ /þ;Ctnnb1tm2Kem/tm2Kem
ifen and progesterone as described. (A), (B) E18.5 male UGSs were stained by ISH to
lue arrowheads indicate ventral prostatic buds, red arrowheads are anterior prostatic
mean7SE of ﬁve independent samples per group from at least three litters. Asterisks
s from three UGSs per genotype UGS sections were immunoﬂuorescently labeled to
ndicate prostatic buds. The arrow in panel E (inset) indicates a representative CTNNB1
V. Mehta et al. / Developmental Biology 376 (2013) 125–135 129Ctnnb1-immunopositive cells are more likely than Ctnnb1-
immunonegative UGE cells to become KRT14þ basal epithelium
We next determined whether Ctnnb1 confers an advantage to
UGE cells to integrate into or be maintained in the KRT14þ multi-
cell layer. We generated Ctnnb1iLOF;R26R and control mice and
used the b-galactosidase assay to label E18.5 UGE cells in which
ShhcreERT2 had been activated. We then calculated the LacZþ cell
percentage contained within the KRT14þ UGE multi-cell layer.
This cell population is signiﬁcantly smaller in Ctnnb1iLOF;R26R
compared to control mice (Fig. 3A–C).
To determine whether Ctnnb1 is required or advantageous for
KRT14þ cell proliferation, we assessed in each genotype the
Ki67þ cell percentage within the LacZþ;KRT14þ cell population
(Fig. 3A, B). Surprisingly, there were no differences in this
proliferative index between Ctnnb1iLOF;R26R and control mice
(Fig. 3D). Together, these results suggest CTNNB1 participates in
the differentiation or maintenance of KRT14þ UGS basal epithe-
lial cells but is not required for their proliferation.
UGE cells with excess Ctnnb1 act non-autonomously to impair
prostatic bud formation
Results from Ctnnb1cLOF and Ctnnb1iLOF mice suggest Ctnnb1 is
necessary for formation of basal epithelium and prostatic buds.
We tested whether excess CTNNB1 expression in UGE would
independently drive either of these processes. We generated mice
harboring ShhcreERT2 and the inducible conditional dominant
stable Ctnnb1tm1Mmt gain of function (GOF) allele (Ctnnb1iGOF
mice). These mice harbor a ﬂoxed Ctnnb1 exon 3 which when
subjected to cre-mediated recombination encodes a functionalFig. 3. Ctnnb1-positive cells are more likely than Ctnnb1-negative cells to become U
ShhcreERT2/þ;Ctnnb1tm2Kem/tm2Kem;R26Rþ (Ctnnb1iLOF;R26R) embryos were exposed to tam
LacZ activity, embedded in parafﬁn, sectioned and immunoﬂuorescently labeled to det
were captured, inverted, pseudocolored yellow and merged with ﬂuorescent images. N
genotype. Arrowheads indicate prostatic buds. (C) The LacZþ cell percentage of KRT14
three independent samples per group from at least three litters. Asterisks indicate signand highly stable CTNNB1 protein form that accumulates in cells.
Cre activity was induced, as described above, by tamoxifen:pro-
gesterone administration to the dam on E13.5 and 14.5. All
assessments were made at E18.5, after completion of prostatic
bud formation in control mice.
We expected Ctnnb1iGOF UGSs to form at least as many, if not
more prostatic buds compared to control UGSs. We instead
observed fewer ventral, dorsolateral, anterior and total Nkx3-1þ
prostatic buds in Ctnnb1iGOF UGSs compared to control UGSs
(Fig. 4A C). In fact, to our surprise there were fewer buds in
Ctnnb1iGOF than in Ctnnb1iLOF mice. We also identiﬁed an unusual
histological feature in Ctnnb1iGOF mice: dense cadherin 1 (CDH1)-
positive epithelial cell islands, four to eight cells in diameter and
with varying degrees of organization, interrupting the otherwise
normal urothelial histotype of Ctnnb1iGOF UGS and bladder trigone
(Fig. 4). Excess CTNNB1 protein is present in membranes, cyto-
plasm and nuclei of all Ctnnb1iGOF epithelial island cells (Fig. 4D,
E); whereas normal CTNNB1 protein levels are present and
localized only to cell membranes of control mouse UGE cells.
Nearly all Ctnnb1iGOF UGE cell islands are accompanied by stromal
invasion into the UGE which was visualized by marking UGS
stroma with the submucosa/lamina propria marker (Abler et al.,
2011a) forkhead box F1a, Foxf1a (Fig. 4F, G). We also identiﬁed
inappropriate expression of CTNNB1-responsive Axin2, Lef1 and
Wif1 mRNAs in the cell islands (Fig. 4H–M) and an inappropriate
reduction of these markers in associated UGS stroma. In age-
matched control mouse UGE, epithelial expression of Axin2, Lef1
andWif1mRNAs is normally restricted to prostatic buds and each
mRNA is abundant in associated UGS stroma.
We next tested whether expression of excess Ctnnb1 was
sufﬁcient for imposing prostate identity onto UGE. Nkx3-1, theGS basal epithelium. Male ShhcreERT2/þ;Ctnnb1tm2Kem/þ;R26Rþ (control;R26R) and
oxifen and progesterone as described. (A), (B) E18.5 UGSs were stained to visualize
ect the cell proliferation marker Ki67 and KRT14. Brightﬁeld LacZ staining images
uclei were stained with DAPI. Staining patterns represent at least three UGSs per
þ cells and (D) the Ki67þ cell percentage of LacZþ;KRT14þ cells are mean7SE of
iﬁcant differences from controls (po0.05).
Fig. 4. Excess CTNNB1 in UGE impairs prostatic bud formation and causes an inappropriate pattern of CTNNB1-responsive mRNA expression. Male Shhþ /þ; Ctnnb1tm1Mmt/tm1Mmt
(control) and ShhcreERT2/þ;Ctnnb1tm1Mmt/tm1Mmt (Ctnnb1iGOF) embryos were exposed to tamoxifen and progesterone as described. (A), (B) E18.5 male UGSs were stained by ISH to
visualize Nkx3-1 (purple) and counterstained by IHC to visualize UGE marked by CDH1. Blue arrowheads indicate ventral prostatic buds, red arrowheads are anterior prostatic
buds and green arrowheads are dorsolateral prostatic buds. (C) Nkx3-1þ bud numbers are mean7SE of ﬁve independent samples per group from at least three litters. Asterisks
indicate signiﬁcant differences from controls (po0.05). (D–M) Sections from three UGSs per genotype were immunoﬂuorescently labeled to visualize CTNNB1 and CDH1
proteins or stained by ISH to visualize mRNA expression (purple) of the urethra lamina propria mesenchyme Foxf1a or the CTNNB1 responsive genes Axin2, Lef1 and Wif1.
Sections were immunoﬂuorescently counterstained to visualize UGE marked by CDH1. Abbreviations are bl: bladder, sv: seminal vesicle. Arrowheads indicate prostatic buds.
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Fig. 5. Excess CTNNB1 in UGE is not sufﬁcient for prostate identity but is sufﬁcient
for basal epithelial cell differentiation. Male Shhþ /þ; Ctnnb1tm1Mmt/tm1Mmt (control)
and ShhcreERT2/þ; Ctnnb1tm1Mmt/tm1Mmt (Ctnnb1iGOF) embryos were exposed to
tamoxifen and progesterone as described. (A), (B), (E)–(H) At E18.5, UGS sections
were stained by ISH to visualize mRNAs (purple) for the prostatic bud marker
Nkx3-1, the basal epithelial marker Krt5 and the intermediate and superﬁcial
urothelial marker Upk1b. Sections were immunoﬂuorescently counterstained to
visualize UGE marked by CDH1. (C)–(D) E18.5 male UGS sections were immuno-
ﬂuorescently labeled to visualize CTNNB1 and the basal epithelial marker TRP63.
Staining patterns in each panel represent three males. Abbreviations are bl:
bladder, sv: seminal vesicle. Arrowheads indicate prostatic buds.
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et al., 1997), localizes to prostatic buds in Ctnnb1iGOF and control
UGSs but is not visible in Ctnnb1iGOF cell islands with excess
CTNNB1 protein expression (Fig. 5A, B). These results indicate that
expression of excess CTNNB1 is insufﬁcient for imposing Nkx3-1þ
prostatic identity onto UGE.
Since Ctnnb1cLOF UGSs do not form a well developed basal
epithelium (Fig. 1G, H) and since there are fewer Ctnnb1þ UGE
basal epithelial cells (Fig. 3C), we assessed whether expression of
excess CTNNB1 in UGE is sufﬁcient for imposing a basal cell
identity on UGE. Ctnnb1iGOF cell islands feature a TRP63þ;Krt5þ
basal epithelial sheath (Fig. 5C–F) and a TRP63-;Krt5- cell core
that lacks detectable uroplakin 1b (Upk1b)–a marker of the only
other known urothelial cell type (Abler et al., 2011a) present in
E18.5 control mouse urethra (Fig. 5G, H). Together, these results
provide evidence for self-organizing activity in Ctnnb1iGOF cell
islands, reveal that some cells with excess CTNNB1 express basal
epithelial cell markers and that others inappropriately retain a
primitive, undifferentiated UGE cell histotype.
Expression of excess Ctnnb1 in UGE impairs prostatic bud formation
by a paracrine mechanism involving bone morphogenetic protein
signaling
CTNNB1 inﬂuences skin appendage patterning by inducing
formation of hair and feather placodes and by establishing
placode spacing intervals (Chang et al., 2004; Zhang et al.,
2009). We considered the possibility that CTNNB1 within pro-
static bud tips may control prostatic bud spacing by suppressing
bud formation elsewhere in UGS epithelium. In the case of
Ctnnb1iGOF UGSs, such a bud spacing mechanism would be
precociously or prematurely activated in cell islands to suppress
prostatic buds in a much larger domain—throughout the entire
UGE, and would provide a rationale for how prostatic bud
formation is inhibited in this mouse strain. Bone morphogenetic
proteins (BMPs) are known inhibitors of prostatic bud formation.
Bmp4 and Bmp7 mRNAs are expressed in the UGS during prostatic
bud formation, addition of exogenous BMP4 or BMP7 protein to
organ culture media inhibits prostatic bud formation in vitro, and
genetic deletion of the BMP antagonist Noggin inhibits prostatic
bud formation in vivo (Cook et al., 2007; Grishina et al., 2005;
Lamm et al., 2001; Vezina et al., 2008). However, mechanisms
regulating Bmp expression in UGS epithelium have not been
determined. We tested the hypothesis that CTNNB1 induces
BMP ligand expression in UGE. We observe low-level expression
of Bmp 2, 4 and 7 mRNAs where CTNNB1-responsive Axin2 and
Lef1 mRNAs are localized in prostatic bud tips of control UGSs
(Fig. 6A, C, E). Each Bmp is highly abundant in Ctnnb1iGOF cell
islands with excess CTNNB1 (Fig. 6B, D, F) suggesting CTNNB1-
dependent activation of BMP ligand expression.
BMPs elicit their activity in part by binding BMP receptors and
inducing SMAD protein phosphorylation to prompt assembly of a
heterodimeric transcription factor complex. We used an antibody
that speciﬁcally recognizes BMP-responsive phosphorylation of
SMAD (pSMAD) 1/5/8 to determine whether BMPs were activat-
ing downstream signaling in the UGS. In control UGS, pSMAD1/5/
8 immunostaining was present in UGM and UGE (Fig. 6G). We
noted a speciﬁc trend in pSMAD1/5/8 distribution in UGE: it was
more abundant in the base of prostatic buds (Fig. 6G, white
arrows) than in prostatic bud tips (Fig. 6G, yellow arrows). This
pattern is the inverse of CTNNB1-responsive Axin2, Lef1 and Wif1
mRNA expression in control UGE, which are more abundant in
prostatic bud tips than elsewhere in prostatic buds (Fig. 4H,J,L).
pSMAD1/5/8 was noticeably more abundant in Ctnnb1iGOF UGS
than in control UGS (Fig. 6H), and particularly in UGE surrounding
Ctnnb1iGOF cell islands with excess CTNNB1 (Fig. 6H, white
Fig. 6. Excess CTNNB1 in UGE induces BMP expression and increases BMP signaling.
E18.5 Male Shhþ /þ;Ctnnb1tm1Mmt/tm1Mmt (control) and ShhcreERT2/þ;Ctnnb1tm1Mmt/tm1Mmt
(Ctnnb1iGOF) embryos were exposed to tamoxifen and progesterone as described. (A)–
(F) Sections stained by ISH to visualize mRNA expression (purple) of Bmp 2, 4 and 7
Black arrowheads indicate prostatic bud tips. (G), (H) Sections immunoﬂuorescently
labeled to visualize CTNNB1 (green), phospho-SMAD (pSMAD) 1/5/8 (red) and nuclei
stained with DAPI (blue). White lines demarcate the interface between UGE and UGM.
Yellow arrows indicate cells in which CTNNB1 is known to be high (prostatic bud tips
in G and CTNNB1 cell islands in H). White arrows indicate cells surrounding those with
high CTNNB1. Abbreviations are bl: bladder, sv: seminal vesicle.
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arrowheads). Again, this pattern is the inverse of Ctnnb1-respon-
sive mRNA expression in the Ctnnb1iGOF UGS (Fig. 4I,K,M). These
results reveal an important trend: active BMP signaling in fetal
mouse UGE is typically localized to a cell ﬁeld surrounding, but
not within cells where CTNNB1 signaling exists.
If an overabundance of BMP signaling contributes to prostatic
bud impairment in Ctnnb1iGOF UGSs, we hypothesized that the BMP
inhibitor NOGGIN would at least partially restore prostatic bud
formation. E14.5 male Ctnnb1iGOF and control UGSs were grown in
organ culture media containing 4-hydroxytamoxifen, DHT and
either vehicle or recombinant NOGGIN protein. We conﬁrmed this
4-hydroxytamoxifen concentration activates creERT2 (supplemen-
tary material Fig. S1H) and does not alter prostatic bud number in
control UGS explants (supplementary material Fig. S6). The con-
centration of recombinant NOGGIN protein (1 mg/ml) used in this
study was used previously to antagonize BMP signaling in control
mouse UGS explants (Cook et al., 2007; Vezina et al., 2008). In the
absence of exogenous NOGGIN, Ctnnb1iGOF UGSs form fewer Nkx3-1
positive prostatic buds compared to control cultured UGSs (Fig. 7A,
B, E). Exogenous NOGGIN increased Nkx3-1-positive bud number in
Ctnnb1iGOF UGSs (Fig. 7C–E) but did not signiﬁcantly change
prostatic bud number in control UGSs (Fig. 7A, C, E). These results
indicate a genetic sensitivity of Ctnnb1iGOF UGSs to NOGGIN and
support the notion that excess BMP signaling is a potential
mechanism for prostatic bud impairment in Ctnnb1iGOF UGSs.
Taken together, our results support the hypothesis that CTNNB1
activation in prostatic bud tips participate in prostatic bud spacing
by activating BMP signaling to inhibit inappropriate prostatic bud
formation in surrounding UGE.Discussion
Two different Ctnnb1 actions are revealed in the developing prostate
A recent report indicated a required role for CTNNB1 in
prostatic bud initiation (Simons et al., 2012). Our results extend
those ﬁndings by showing that prostatic bud formation speciﬁcally
requires CTNNB1 in UGS epithelium. We also identiﬁed two crucial
Ctnnb1 roles in prostate development that have not been reported
previously. Ctnnb1 is ﬁrst required in UGS epithelium prior to
prostatic budding where it is hypothesized to promote formation
of KRT14þ UGS basal epithelium (Fig. 8A). Ctnnb1 is then activated
in prostatic bud tips where it is hypothesized to inhibit additional
bud formation by activating BMP signaling (Fig. 8B). Together,
these Ctnnb1 actions provide a rationale for how modiﬁcation of
CTNNB1 signaling in either a positive (increased signaling) or
negative (decreased signaling) direction can elicit deleterious
effects on early prostate development. This also suggests a neces-
sity for strict CTNNB1 regulation during prostate development to
give rise to an appropriately patterned ductal network.
Ctnnb1 promotes UGS basal epithelium
We provide multiple lines of evidence to support a Ctnnb1 role
in formation of UGS basal epithelium. First, we found that Ctnnb1
deletion from all UGS epithelial cells at an early stage of prostate
development prevents formation of KRT14þ UGS basal epithe-
lium. Second, we observed that cells with functional CTNNB1 are
more likely than cells without functional CTNNB1 to establish or
maintain KRT14 expression. Third, we found that UGS epithelial
cell islands expressing excess CTNNB1 develop their own basal
cell layer. Taken together, these results directly implicate Ctnnb1
in promoting or maintaining basal epithelial identity in develop-
ing prostate.
Fig. 7. BMP signaling inhibition in cultured UGS with excess CTNNB1 partially restores prostatic bud formation. E14.5 male Shhþ /þ;Ctnnb1tm1Mmt/tm1Mmt (control) and
ShhcreERT2/þ;Ctnnb1tm1Mmt/tm1Mmt (Ctnnb1iGOF) UGSs were incubated for 4 days in organ culture medium containing 1 mm 4-hydroxytamoxifen, 10 nM 5a dihydrotestoster-
one and either vehicle or recombinant NOGGIN protein (rNOGGIN, 1 mg/ml). Media and supplements were replenished after the second day. (A)–(D). Whole UGSs were
stained by ISH to visualize Nkx3-1 mRNA (purple). Abbreviations are bl: bladder, sv: seminal vesicle. (E) Nkx3-1þ bud numbers are mean7SE of ﬁve independent samples
per group from at least three litters. Asterisks indicate a signiﬁcant difference (po0.05) in prostatic bud number compared to Ctnnb1iGOF UGS grown in the absence of
rNOGGIN.
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CTNNB1 supports UGS basal epithelial development, our results
argue against a pro-proliferative action. We found that once
KRT14þ cells had formed, Ctnnb1 was not needed or advantageous
for their proliferation. Instead, Ctnnb1 is likely to either initiate or
maintain basal cell differentiation. The former possibility isconsistent with the established CTNNB1 function in adult prostate
progenitor cells. Activation of LRP5, a WNT co-receptor, expands
the proportion of TRP63þ basal epithelial cells during in vitro
prostate sphere formation (Shahi et al., 2012). In vitro treatment of
the same enriched prostate progenitor cell population with
WNT3A conditioned media re-patterns TRP63þ cells within,
Fig. 8. Proposed dichotomous CTNNB1 activity during mouse prostate development. (A) During early prostate development, functional CTNNB1 in primitive UGS
epithelium supports formation or maintenance of mature KRT14þ basal epithelium, which is needed for prostatic bud formation. (B) During prostatic bud formation and
elongation, CTNNB1 is activated in prostatic bud tips where it initiates BMP 2, 4 and 7 synthesis, which act upon UGS epithelium to prevent additional buds from forming.
We propose that these CTNNB1 mechanisms in part establish prostatic bud spacing intervals.
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important in future studies to determine speciﬁcally how Ctnnb1
promotes basal epithelial cell identity within the UGE progenitor
population, whether this process is reversible and whether the
progenitors are multipotent and capable of giving rise to non-basal
lineages (intermediate or superﬁcial epithelium).
Ctnnb1 participates in prostatic bud spacing
Ctnnb1 gain-of-function mutations cause supernumerary bud
formation in several developing organs (Faraldo et al., 2006; Gat
et al., 1998; Liu et al., 2007; Lo Celso et al., 2004; Noramly et al.,
1999; Widelitz et al., 2000). Yet, intriguingly in prostate, CTNNB1
stabilization is not sufﬁcient for inducing supernumerary pro-
static bud formation, at least not in the speciﬁc UGS epithelial cell
type and developmental stages examined herein. Instead, we
found that prostatic bud formation requires Ctnnb1 in combina-
tion with other factors.
Because expression of excess Ctnnb1 in a mosaic of UGE cells
globally inhibited prostatic bud formation, we further hypothe-
sized that Ctnnb1 impaired prostatic bud formation through a
paracrine or juxtacrine mechanism. We linked CTNNB1 to pro-
static bud inhibitory actions by involving increased BMP signaling
as indicated in the discussion below.
We identiﬁed Bmp signaling as a downstream mediator of
CTNNB1 function in UGE. We found that Ctnnb1iGOF cell islands
express Bmp 2, 4 and 7 mRNAs and that BMP-responsive phospho-
SMAD1/5/8 is expressed in adjacent UGE but not in UGE island cells
excess CTNNB1. We also found that BMP signaling antagonism by
NOGGIN partially restored prostatic bud formation in Ctnnb1iGOF UGS
explants and Ctnnb1iGOF UGSs are more sensitive than control UGSs to
exogenous NOGGIN-induced increases in prostatic bud formation.
These results identify BMP signaling as one mechanism by which
prostatic budding is impaired in Ctnnb1iGOF UGSs. It is important to
note that the NOGGIN concentration used in this study was not
capable of fully rescuing prostatic bud formation in Ctnnb1iGOF UGSs.
Whether a greater NOGGIN concentration would have caused a
greater rescue of prostatic bud formation is not known and whether
other CTNNB1-responsive signaling pathways contribute to prostatic
budding impairment in Ctnnb1iGOF UGSs was not determined.
Furthermore, additional studies are needed to determine how
Ctnnb1iGOF cell islands are protected from the BMPs they synthesize.
Little is known about how prostatic bud spacing intervals are
achieved. In the absence of androgens or intact AR signaling, small
epithelial buds form in an inappropriate pattern in the ventral aspect
of the mouse UGS (Allgeier et al., 2010). Though these small buds do
not elongate, their androgen-independent formation is importantbecause it suggests prostatic bud initiation can occur independently
of androgens and that androgens participate in prostatic bud pattern-
ing (Allgeier et al., 2010). Prostatic bud patterning mechanisms are
not fully known. Results from this and other studies support CTNNB1
as a regulatory node for controlling prostatic bud patterning. We
previously showed that high levels of androgen signaling in male
mouse UGS are associated with CTNNB1-responsive Axin2 and Lef1
expression in prostatic bud tips (Mehta et al., 2011). Bmp mRNAs are
also expressed in prostatic bud tips; in this study, we provide
evidence that CTNNB1 induces Bmp expression in this location. The
BMP signaling pathway is one of few identiﬁed endogenous antago-
nists of prostatic bud formation (Cook et al., 2007; Grishina et al.,
2005; Lamm et al., 2001). Fine tuning of BMP signaling has been
reported as a CTNNB1 action in skin appendage spacing (Zhang et al.,
2008). Likewise, results from this study support the hypothesis that
CTNNB1 activity acts as a mechanism for ﬁne tuning of BMP
expression in UGS epithelium during the emergence of prostatic
buds. Other mechanisms are also likely to contribute to prostatic bud
spacing, especially during prostatic bud initiation when BMPs dom-
inate in UGS mesenchyme (Grishina et al., 2005; Lamm et al., 2001).
It is unclear how nascent prostatic buds overcome bud
inhibitory BMP signals from UGS stroma and how prostatic bud
tips are protected from the bud inhibitory BMPs they produce.
One potential protective mechanism for prostatic buds is Noggin,
which is highly expressed in UGS mesenchyme near prostatic bud
tips and is least abundant in mesenchyme near interbud UGE
(Cook et al., 2007). This particular expression pattern would allow
for maximal sequestration of BMPs near prostatic bud tips to
permit their outgrowth and maximal BMP activity in interbud
UGS epithelium to limit/restrict additional/new bud formation.Funding
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